Gratry & Company’s Amgen AMGN Stock Holding History

Gratry & Company’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-1,645	Closed	-$307K	–	84
2017 Q3	$307K	Hold	1,645	–	–	0.38%	56
2017 Q2	$283K	Sell	1,645 -55	-3%	-$8.95K	0.35%	61
2017 Q1	$279K	Buy	+1,700	New	+$282K	0.34%	64

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Gratry & Company's AMGN Position: Q4 2017 in Review

Gratry & Company sold out of Amgen (AMGN) in Q4 2017, closing a stake of 1,645 shares — an estimated $307K sold.

Gratry & Company first reported a position in AMGN in Q1 2017 and held it in 3 quarters. The position peaked at $307K in Q3 2017. 1,734 funds tracked by Wall St. Rank hold AMGN as of Q4 2017.

Gratry & Company reported no remaining Amgen position as of Q4 2017 after selling out during the quarter.
Gratry & Company sold 1,645 Amgen shares in Q4 2017, an estimated $307K.
Gratry & Company first reported a position in Amgen in Q1 2017 and held it in 3 quarters.
Gratry & Company's Amgen position peaked at $307K in Q3 2017.
1,734 funds tracked by Wall St. Rank held Amgen as of Q4 2017.

Based on Gratry & Company's 13F filing for Q4 2017, filed 5 Feb 2018.